Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colin J McKay

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Annals of Surgery|May 21, 2010
Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinomaNigel B Jamieson, Alan K Foulis, Karin A Oien, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Annals of Surgical Oncology|January 27, 2011
A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinomaNigel B Jamieson, Simon M Denley, Jennifer Logue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2011
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinomaNigel B Jamieson, Douglas C Morran, Jennifer P Morton, et al.
Journal of Gastrointestinal Oncology|September 12, 2017
The role of induction chemotherapy + chemoradiotherapy in localised pancreatic cancer: initial experience in ScotlandDerek Grose, David McIntosh, Nigel Jamieson, et al.
BMC Clinical Pathology|July 30, 2014
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelAsif Ali, Victoria Brown, Simon Denley, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|November 20, 2013
Serum amylase on the night of surgery predicts clinically significant pancreatic fistula after pancreaticoduodenectomyLavanniya K Palani Velu, Vishnu V Chandrabalan, Salman Jabbar, et al.
Annals of Surgery|May 21, 2010
Positive mobilization margins alone do not influence survival following pancreatico-duodenectomy for pancreatic ductal adenocarcinomaNigel B Jamieson, Alan K Foulis, Karin A Oien, et al.
Journal of the National Cancer Institute|August 8, 2015
RE: nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III TrialLavanniya K Palani Velu, Colin W Steele, Euan J Dickson, et al.
Annals of Surgical Oncology|May 5, 2012
The relationship between tumor inflammatory cell infiltrate and outcome in patients with pancreatic ductal adenocarcinomaNigel B Jamieson, Mohamed Mohamed, Karin A Oien, et al.
Plos One|June 30, 2015
SIRT3 & SIRT7: Potential Novel Biomarkers for Determining Outcome in Pancreatic Cancer PatientsLiane M McGlynn, Simon McCluney, Nigel B Jamieson, et al.
Annals of Surgical Oncology|January 27, 2011
A prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinomaNigel B Jamieson, Simon M Denley, Jennifer Logue, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 25, 2011
MicroRNA molecular profiles associated with diagnosis, clinicopathologic criteria, and overall survival in patients with resectable pancreatic ductal adenocarcinomaNigel B Jamieson, Douglas C Morran, Jennifer P Morton, et al.
Journal of Gastrointestinal Oncology|September 12, 2017
The role of induction chemotherapy + chemoradiotherapy in localised pancreatic cancer: initial experience in ScotlandDerek Grose, David McIntosh, Nigel Jamieson, et al.
BMC Clinical Pathology|July 30, 2014
Expression of KOC, S100P, mesothelin and MUC1 in pancreatico-biliary adenocarcinomas: development and utility of a potential diagnostic immunohistochemistry panelAsif Ali, Victoria Brown, Simon Denley, et al.
Chinese Clinical Oncology|May 10, 2019
Feasibility and clinical utility of endoscopic ultrasound guided biopsy of pancreatic cancer for next-generation molecular profilingStephan B Dreyer, Nigel B Jamieson, Lisa Evers, et al.
Pageof 5